● Recruiting

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Condition: Meningioma · Sponsor: Baptist Health South Florida

PhasePhase 2

Planned participants24

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

This description comes directly from the study's public registry record.

Talk to the study team

Rupesh Kotecha, M.D. · (786) 596-2000 · RupeshK@baptisthealth.net

Anais Vega · (786) 596-2000 · anais.vega@baptisthealth.net

Always discuss trial participation with your own doctor first.

Locations (3)

Miami Cancer Institute at Baptist Health, Inc.	Miami, Florida, United States	Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
Vanderbilt University Medical Center	Nashville, Tennessee, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05425004